If you took Ozempic, Wegovy, Mounjaro, Zepbound, or another GLP-1 medication and were later diagnosed with NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) or sudden painless vision loss, you may have seen ads inviting you to sign up for litigation. This article explains what that phrase usually means, how federal cases are coordinated, and what to expect from a free case review. For drug and vision-loss context, see NAION & Ozempic lawsuit information and the NAION & Ozempic lawsuit news hub.
What “Signing Up” Actually Means
In drug injury litigation, “sign up” almost never means adding your name to one master registry that automatically includes you in a payout. It usually means requesting a confidential intake so attorneys can see whether your medical and prescription history fits cases they file. If a law firm accepts you as a client, they file a complaint in court on your behalf. Until then, you are not a plaintiff.
Top Tier Legal, LLC is not a law firm and does not provide legal advice. If your information suggests you may qualify, we may connect you with an independent law firm for evaluation. Submitting information does not create an attorney–client relationship with Top Tier Legal, LLC.
How the NAION / GLP-1 Cases Fit Together
Many federal lawsuits alleging that GLP-1 drugs contributed to NAION are consolidated in MDL No. 3163, *In re: GLP-1 RA Products Liability Litigation (No. II)*, in the U.S. District Court for the Eastern District of Pennsylvania (Judge Karen S. Marston). An MDL coordinates pretrial proceedings—it does not turn your claim into a class action. Each person typically keeps an individual case; outcomes depend on facts, injuries, and proof.
Some cases may proceed in state court or outside the MDL depending on jurisdiction and strategy—those are decisions for licensed counsel.
Step 1: Start a Free, Confidential Case Review
The practical first step is a case review through a channel that connects you with firms handling NAION / GLP-1 claims. On Top Tier Legal, you can begin on our NAION & Ozempic practice page and select the appropriate claim type.
Take the first step: a free consultation could clarify your legal options.
No obligation. A quick review can clarify your next steps.
Start with a free consultationYou will generally be asked when you used a GLP-1 product, what you were prescribed it for, and when vision symptoms or a NAION diagnosis occurred. You do not need a complete medical file to start.
Step 2: Information That Helps Move Your Review Forward
Counsel often finds the following useful (records can follow after the first contact):
- Medication history: Which GLP-1 you used (for example semaglutide or tirzepatide products), approximate start and stop dates, and dose changes if you know them.
- Vision care records: Ophthalmology or optometry notes, diagnosis of NAION or documentation of sudden vision loss, imaging or visual field testing if available.
- Timeline: When vision symptoms began relative to when you started the medication—many evaluations focus on symptoms after initiation of therapy.
Step 3: If a Law Firm Accepts Your Case
If a firm believes it can represent you, it will explain fees, scope of work, and next steps—often including signing a retainer agreement. Many firms handle these cases on a contingency basis, but you should read any agreement carefully and ask questions.
Your attorneys then prepare and file a complaint and handle court procedures, including possible transfer or tagging into the MDL for federal cases that qualify. You do not manage MDL mechanics yourself.
Deadlines Matter
Statutes of limitations vary by state and can depend on when you discovered or should have discovered harm. Missing a deadline can bar a claim. Because this area is fact-specific, rely on a licensed attorney for deadline advice. Starting a review early preserves options.
Top Tier Legal connects you with experienced mass tort attorneys.
Get a free case review and learn whether you may qualify.
Get a free case evaluationWhere to Read Next
- Eligibility and science overview: NAION & Ozempic vision loss claims
- Litigation updates: NAION & Ozempic lawsuit news & updates
- Broader drug-injury context: Dangerous drugs
- How mass tort cases work: Understanding mass tort litigation
If you used a GLP-1 drug and later developed NAION or sudden vision loss, a confidential case review may help you understand whether exploring legal action makes sense for your situation.
Frequently asked questions (Quick reference)
- Q: Which issues does this overview of How to Sign Up for the NAION Ozempic Lawsuit address?
- It organizes key ideas about How to Sign Up for the NAION Ozempic Lawsuit for readers researching "Drug Safety". Nuances depend on facts and jurisdiction.
- Q: Can I treat this post as advice from a lawyer?
- No. For legal guidance you need advice from lawyers who review your facts. Top Tier Legal, LLC connects qualified users with separate law firms.
- Q: Where can I seek a no-cost case evaluation that may touch on How to Sign Up for the NAION Ozempic Lawsuit?
- Submit a request via the firm's published intake pathways. Availability of a review does not imply you will qualify for litigation.
- Q: How does Top Tier Legal connect readers with attorneys?
- It does not sue on your behalf. Instead, qualifying individuals may receive an introduction so an outside lawyer can investigate.
- Q: Do deadlines commonly apply when someone considers action related to How to Sign Up for the NAION Ozempic Lawsuit?
- Regulators and courts impose strict filing windows for many disputes. Attorneys can clarify what clock might apply.
Top Tier Legal, LLC is not a law firm and does not provide legal advice. This content is for informational purposes only. Submitting information does not create an attorney-client relationship. If you qualify, Top Tier Legal, LLC may connect you with an independent law firm. Past results do not guarantee future outcomes.


